Medications

acalabrutinib

Tyrosine Kinase Inhibitors

Approved use in

B-Cell Prolymphocytic Leukemia, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenström's Macroglobulinemia

alemtuzumab

Monoclonal Antibodies

Approved use in

Adult T-cell Leukemia / Lymphoma, B-Cell Prolymphocytic Leukemia, Chronic Lymphocytic Leukemia, Cutaneous T-Cell Lymphoma, Large Granular Lymphocytic Leukemia, T-Cell Prolymphocytic Leukemia

all-trans retinoic acid

Antineoplastic Agents

Approved use in

Adult T-cell Leukemia / Lymphoma

Asciminib

Tyrosine Kinase Inhibitors

Approved use in

Chronic Myeloid Leukemia

asparaginase

Enzyme-Based Chemotherapy

Approved use in

Lymphoblastic Lymphoma

Avapritinib

Tyrosine Kinase Inhibitors

Approved use in

Chronic Eosinophilic Leukemia, Systemic Mastocytosis

axicabtagene ciloleucel

CAR T-Cell Therapy

Approved use in

Follicular Lymphoma, Large B Cell Lymphoma

azacitidine

Chemotherapy Agents

Approved use in

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Juvenile Myelomonocytic Leukemia, Large Granular Lymphocytic Leukemia, Myelodysplastic Syndromes

belantamab mafodotin

Antibody-Drug Conjugates

Approved use in

Multiple Myeloma

Belinostat

Targeted Therapies

Approved use in

Cutaneous T-Cell Lymphoma, Peripheral T-Cell Lymphoma

benralizumab

Monoclonal Antibodies

Approved use in

Chronic Eosinophilic Leukemia

bleomycin

Antineoplastic Agents

Approved use in

Hodgkin Lymphoma

blinatumomab

Bispecific Antibodies

Approved use in

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma

Bortezomib (Velcade)

Proteasome Inhibitors

Approved use in

Adult T-cell Leukemia / Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Multiple Myeloma, Waldenström's Macroglobulinemia

Bosutinib

Tyrosine Kinase Inhibitors

Approved use in

Chronic Myeloid Leukemia

brentuximab vedotin

Antibody-Drug Conjugates

Approved use in

Adult T-cell Leukemia / Lymphoma, Anaplastic Large Cell Lymphoma, Cutaneous T-Cell Lymphoma, Hodgkin Lymphoma, Large B Cell Lymphoma, Peripheral T-Cell Lymphoma

brexucabtagene autoleucel

CAR T-Cell Therapy

Approved use in

Mantle Cell Lymphoma

Cabazitaxel (Jevtana)

Chemotherapy Agents

Approved use in

Prostate Cancer

Calaspargase pegol

Enzyme-Based Chemotherapy

Approved use in

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma

carboplatin

Chemotherapy Agents

Approved use in

Adult T-cell Leukemia / Lymphoma, Anaplastic Large Cell Lymphoma, Hodgkin Lymphoma, Mantle Cell Lymphoma, Peripheral T-Cell Lymphoma

carfilzomib

Proteasome Inhibitors

Approved use in

Multiple Myeloma

ceritinib

Tyrosine Kinase Inhibitors

Approved use in

Peripheral T-Cell Lymphoma

Chlorambucil

Chemotherapy Agents

Approved use in

Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma, Polycythemia Vera

Ciltacabtagene autoleucel (Carvykti)

CAR T-Cell Therapy

Approved use in

Multiple Myeloma

cladribine

Chemotherapy Agents

Approved use in

B-Cell Prolymphocytic Leukemia, Chronic Lymphocytic Leukemia, Hairy Cell Leukemia, Large Granular Lymphocytic Leukemia, Systemic Mastocytosis, T-Cell Prolymphocytic Leukemia

Clofarabine

Chemotherapy Agents

Approved use in

Acute Lymphoblastic Leukemia

crizotinib

Tyrosine Kinase Inhibitors

Approved use in

Anaplastic Large Cell Lymphoma, Peripheral T-Cell Lymphoma

cytarabine

Chemotherapy Agents

Approved use in

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adult T-cell Leukemia / Lymphoma, Anaplastic Large Cell Lymphoma, Blastic Plasmacytoid Dendritic Cell Neoplasm, Burkitt Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Cutaneous T-Cell Lymphoma, Juvenile Myelomonocytic Leukemia, Large B Cell Lymphoma, Lymphoblastic Lymphoma, Mantle Cell Lymphoma, Peripheral T-Cell Lymphoma, Systemic Mastocytosis, T-Cell Prolymphocytic Leukemia

dabrafenib

Targeted Therapies

Approved use in

Hairy Cell Leukemia

dacarbazine

Chemotherapy Agents

Approved use in

Hodgkin Lymphoma

danazol

Androgens

Approved use in

Myelofibrosis

daratumumab

Monoclonal Antibodies

Approved use in

Multiple Myeloma

dasatinib

Tyrosine Kinase Inhibitors

Approved use in

Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia, Lymphoblastic Lymphoma

daunorubicin

Chemotherapy Agents

Approved use in

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Eosinophilic Leukemia, Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Cutaneous T-Cell Lymphoma, Juvenile Myelomonocytic Leukemia, Lymphoblastic Lymphoma, Systemic Mastocytosis

decitabine

Chemotherapy Agents

Approved use in

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes

dexamethasone

Systemic Steroids

Approved use in

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Burkitt Lymphoma, Chronic Lymphocytic Leukemia, Follicular Lymphoma, Large B Cell Lymphoma, Lymphoblastic Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Myelofibrosis, Waldenström's Macroglobulinemia

Diethylstibestrol (DES)

GnRH/LHRH Hormone Therapy

Approved use in

Prostate Cancer

doxorubicin

Chemotherapy Agents

Approved use in

Acute Lymphoblastic Leukemia, Adult T-cell Leukemia / Lymphoma, Anaplastic Large Cell Lymphoma, B-Cell Prolymphocytic Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Burkitt Lymphoma, Cutaneous T-Cell Lymphoma, Follicular Lymphoma, Hodgkin Lymphoma, Large B Cell Lymphoma, Lymphoblastic Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Multiple Myeloma, Peripheral T-Cell Lymphoma, Waldenström's Macroglobulinemia

duvelisib

Targeted Therapies

Approved use in

Chronic Lymphocytic Leukemia, Follicular Lymphoma, Peripheral T-Cell Lymphoma

elotuzumab

Monoclonal Antibodies

Approved use in

Multiple Myeloma

Elranatamab

Bispecific Antibodies

Approved use in

Multiple Myeloma

enasidenib

Targeted Therapies

Approved use in

Acute Myeloid Leukemia, Myelodysplastic Syndromes

epcoritamab

Bispecific Antibodies

Approved use in

Follicular Lymphoma, Large B Cell Lymphoma

epirubicin

Chemotherapy Agents

Approved use in

B-Cell Prolymphocytic Leukemia

Famciclovir

Antiviral/Antineoplastic Agents

Approved use in

T-Cell Prolymphocytic Leukemia

fedratinib

Targeted Therapies

Approved use in

Myelofibrosis

gemtuzumab ozogamicin

Antibody-Drug Conjugates

Approved use in

Acute Myeloid Leukemia

gilteritinib

Tyrosine Kinase Inhibitors

Approved use in

Acute Myeloid Leukemia

glasdegib

Targeted Therapies

Approved use in

Acute Myeloid Leukemia

Glofitamab

Bispecific Antibodies

Approved use in

Large B Cell Lymphoma

Ibritumomab tiuxetan

Radioimmunotherapy Agents

Approved use in

Follicular Lymphoma

ibrutinib

Tyrosine Kinase Inhibitors

Approved use in

B-Cell Prolymphocytic Leukemia, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Multiple Myeloma, T-Cell Prolymphocytic Leukemia, Waldenström's Macroglobulinemia

Idecabtagene Vicleucel

CAR T-Cell Therapy

Approved use in

Multiple Myeloma

idelalisib

Targeted Therapies

Approved use in

B-Cell Prolymphocytic Leukemia, Chronic Lymphocytic Leukemia, Follicular Lymphoma

ifosfamide

Chemotherapy Agents

Approved use in

Adult T-cell Leukemia / Lymphoma, Anaplastic Large Cell Lymphoma, Burkitt Lymphoma, Large B Cell Lymphoma, Lymphoblastic Lymphoma, Peripheral T-Cell Lymphoma

imatinib

Tyrosine Kinase Inhibitors

Approved use in

Acute Lymphoblastic Leukemia, Chronic Eosinophilic Leukemia, Chronic Myeloid Leukemia, Lymphoblastic Lymphoma, Systemic Mastocytosis

imetelstat

Telomerase Inhibitors

Approved use in

Myelodysplastic Syndromes, Myelofibrosis

inotuzumab ozogamicin

Antibody-Drug Conjugates

Approved use in

Acute Lymphoblastic Leukemia, Follicular Lymphoma, Lymphoblastic Lymphoma

isatuximab

Monoclonal Antibodies

Approved use in

Multiple Myeloma

Isotretinoin

Antineoplastic Agents

Approved use in

Juvenile Myelomonocytic Leukemia

ivosidenib

Targeted Therapies

Approved use in

Acute Myeloid Leukemia, Myelodysplastic Syndromes

ixazomib

Proteasome Inhibitors

Approved use in

Multiple Myeloma

lenalidomide

Immunomodulatory Agents

Approved use in

Adult T-cell Leukemia / Lymphoma, Chronic Lymphocytic Leukemia, Follicular Lymphoma, Large B Cell Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Myelofibrosis

lisocabtagene maraleucel

CAR T-Cell Therapy

Approved use in

Follicular Lymphoma, Large B Cell Lymphoma, Mantle Cell Lymphoma

mepolizumab

Monoclonal Antibodies

Approved use in

Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia

mercaptopurine

Chemotherapy Agents

Approved use in

Acute Lymphoblastic Leukemia, Chronic Myelomonocytic Leukemia, Juvenile Myelomonocytic Leukemia, Lymphoblastic Lymphoma

methotrexate

Chemotherapy Agents

Approved use in

Acute Lymphoblastic Leukemia, Adult T-cell Leukemia / Lymphoma, Anaplastic Large Cell Lymphoma, Blastic Plasmacytoid Dendritic Cell Neoplasm, Burkitt Lymphoma, Cutaneous T-Cell Lymphoma, Large B Cell Lymphoma, Large Granular Lymphocytic Leukemia, Lymphoblastic Lymphoma, Mantle Cell Lymphoma, Peripheral T-Cell Lymphoma

midostaurin

Tyrosine Kinase Inhibitors

Approved use in

Acute Myeloid Leukemia, Chronic Eosinophilic Leukemia, Systemic Mastocytosis

mitoxantrone

Chemotherapy Agents

Approved use in

Acute Myeloid Leukemia, B-Cell Prolymphocytic Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Chronic Eosinophilic Leukemia, Hodgkin Lymphoma, Systemic Mastocytosis, T-Cell Prolymphocytic Leukemia

mogamulizumab

Monoclonal Antibodies

Approved use in

Adult T-cell Leukemia / Lymphoma, Cutaneous T-Cell Lymphoma

momelotinib

Targeted Therapies

Approved use in

Myelofibrosis

mosunetuzumab

Bispecific Antibodies

Approved use in

Follicular Lymphoma

nelarabine

Chemotherapy Agents

Approved use in

Acute Lymphoblastic Leukemia, T-Cell Prolymphocytic Leukemia

nilotinib

Tyrosine Kinase Inhibitors

Approved use in

Chronic Myeloid Leukemia, Lymphoblastic Lymphoma

Niraparib + Abiraterone Acetate (Akeega)

Combination Therapy

Approved use in

Prostate Cancer

nivolumab

Monoclonal Antibodies

Approved use in

Adult T-cell Leukemia / Lymphoma, Anaplastic Large Cell Lymphoma, Hodgkin Lymphoma, Multiple Myeloma, Peripheral T-Cell Lymphoma

Obecabtagene autoleucel

CAR T-Cell Therapy

Approved use in

Acute Lymphoblastic Leukemia

obinutuzumab

Monoclonal Antibodies

Approved use in

B-Cell Prolymphocytic Leukemia, Chronic Lymphocytic Leukemia, Follicular Lymphoma, Large B Cell Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma

ofatumumab

Monoclonal Antibodies

Approved use in

B-Cell Prolymphocytic Leukemia, Chronic Lymphocytic Leukemia, Follicular Lymphoma, Large B Cell Lymphoma, Waldenström's Macroglobulinemia

Olaparib (Lynparza)

Targeted Therapies

Approved use in

Prostate Cancer, T-Cell Prolymphocytic Leukemia

Olutasidenib

Targeted Therapies

Approved use in

Acute Myeloid Leukemia

omalizumab

Monoclonal Antibodies

Approved use in

Systemic Mastocytosis

oxaliplatin

Chemotherapy Agents

Approved use in

Mantle Cell Lymphoma

pacritinib

Targeted Therapies

Approved use in

Chronic Neutrophilic Leukemia, Myelofibrosis

pegaspargase

Enzyme-Based Chemotherapy

Approved use in

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma

Pegylated Interferon Alfa-2a

Immunomodulatory Agents

Approved use in

Adult T-cell Leukemia / Lymphoma, Chronic Eosinophilic Leukemia, Essential Thrombocythemia, Polycythemia Vera

Pembrolizumab (Keytruda)

Immune Therapies

Approved use in

Adult T-cell Leukemia / Lymphoma, Anaplastic Large Cell Lymphoma, Hodgkin Lymphoma, Multiple Myeloma, Peripheral T-Cell Lymphoma, Prostate Cancer

pentostatin

Chemotherapy Agents

Approved use in

B-Cell Prolymphocytic Leukemia, Chronic Lymphocytic Leukemia, Hairy Cell Leukemia, Large Granular Lymphocytic Leukemia, T-Cell Prolymphocytic Leukemia

pirtobrutinib

Tyrosine Kinase Inhibitors

Approved use in

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma

polatuzumab vedotin

Antibody-Drug Conjugates

Approved use in

Follicular Lymphoma, Large B Cell Lymphoma

pomalidomide

Immunomodulatory Agents

Approved use in

Multiple Myeloma, Myelofibrosis

ponatinib

Tyrosine Kinase Inhibitors

Approved use in

Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia

pralatrexate

Chemotherapy Agents

Approved use in

Adult T-cell Leukemia / Lymphoma, Cutaneous T-Cell Lymphoma, Peripheral T-Cell Lymphoma

procarbazine

Chemotherapy Agents

Approved use in

Hodgkin Lymphoma

quizartinib

Tyrosine Kinase Inhibitors

Approved use in

Acute Myeloid Leukemia

rituximab

Monoclonal Antibodies

Approved use in

Acute Lymphoblastic Leukemia, B-Cell Prolymphocytic Leukemia, Burkitt Lymphoma, Chronic Lymphocytic Leukemia, Follicular Lymphoma, Hairy Cell Leukemia, Large B Cell Lymphoma, Large Granular Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Multiple Myeloma, Waldenström's Macroglobulinemia

romidepsin

Targeted Therapies

Approved use in

Cutaneous T-Cell Lymphoma, Peripheral T-Cell Lymphoma

ruxolitinib

Targeted Therapies

Approved use in

Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Cutaneous T-Cell Lymphoma, Essential Thrombocythemia, Large Granular Lymphocytic Leukemia, Myelofibrosis, Polycythemia Vera, T-Cell Prolymphocytic Leukemia

selinexor

Selective Inhibitor of Nuclear Export

Approved use in

Large B Cell Lymphoma, Multiple Myeloma

Tafasitamab

Monoclonal Antibodies

Approved use in

Follicular Lymphoma

tagraxofusp

Targeted Therapies

Approved use in

Blastic Plasmacytoid Dendritic Cell Neoplasm

talquetamab

Bispecific Antibodies

Approved use in

Multiple Myeloma

tazemetostat

Targeted Epigenetic Therapy

Approved use in

Follicular Lymphoma

teclistamab

Bispecific Antibodies

Approved use in

Multiple Myeloma

temsirolimus

Targeted Therapies

Approved use in

Mantle Cell Lymphoma

thalidomide

Immunomodulatory Agents

Approved use in

Multiple Myeloma, Myelofibrosis

tioguanine

Chemotherapy Agents

Approved use in

Lymphoblastic Lymphoma

tisagenlecleucel

CAR T-Cell Therapy

Approved use in

Acute Lymphoblastic Leukemia, Follicular Lymphoma, Large B Cell Lymphoma

Tofacitinib

Targeted Therapies

Approved use in

Cutaneous T-Cell Lymphoma, T-Cell Prolymphocytic Leukemia

trametinib

Targeted Therapies

Approved use in

Hairy Cell Leukemia, Juvenile Myelomonocytic Leukemia

Treosulfan

Chemotherapy Agents

Approved use in

Acute Myeloid Leukemia

trimethoprim

Antibiotics

Approved use in

Adult T-cell Leukemia / Lymphoma, Hairy Cell Leukemia, Large Granular Lymphocytic Leukemia, T-Cell Prolymphocytic Leukemia

Vemurafenib

Targeted Therapies

Approved use in

Hairy Cell Leukemia

venetoclax

Targeted Therapies

Approved use in

Acute Myeloid Leukemia, B-Cell Prolymphocytic Leukemia, Chronic Lymphocytic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Peripheral T-Cell Lymphoma, T-Cell Prolymphocytic Leukemia

zidovudine

Chemotherapy Agents

Approved use in

Adult T-cell Leukemia / Lymphoma